Kara Quan, MD
Clinical Cardiac Electrophysiology · Elyria, OHNPI 1831270826
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,612 of the $36,174 with a category attached, or 84.6%. Abbott accounts for 85.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $26,996 and has fallen 97.9% since, to $577 in 2025.
Across 123 payments — averaging $294.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$31K
- Medtronic$4K
- Biosense Webster, Inc.$431
- Atricure, Inc.$283
- E.r. Squibb & Sons, L.L.C.$161
- Novartis$117
- plus $365 from 8 others
Across 29 payments — averaging $3893.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$108K
- Abbott$5K
What the payments were for
- Consulting fees$30,61285%
- Travel & lodging$2,9948%
- Food & beverage$2,5697%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 43 | $30,780 |
| Medtronic(2 entities) | 30 | $4,038 |
| Biosense Webster, Inc. | 4 | $431 |
| Atricure, Inc. | 13 | $283 |
| E.r. Squibb & Sons, L.L.C. | 9 | $161 |
| Novartis | 6 | $117 |
| Boston Scientific | 2 | $110 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $75 |
| Pfizer | 6 | $73 |
| Cordis US CORP. | 2 | $32 |
| Lexicon Pharmaceuticals, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Cardiva Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Allure CRT Pacemaker$13,409
- Anthem CRT Pacemaker$9,393
- ACCENT$3,800
- Assurity Pacemaker$2,110
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,900
- Arctic Front$1,737
- EVERA MRI XT DR SURESCAN$1,422
- Carto 3$410
- PulseSelect$167
- ENSITE$122
How this compares
$36,174 in reported general payments places this provider in the 70th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 511 | $687,647 |
| XareltoRivaroxaban | 71 | $93,927 |
| EntrestoSacubitril/Valsartan | 46 | $66,082 |
| Dofetilide | 109 | $25,201 |
| MultaqDronedarone Hcl | 12 | $24,703 |
| Metoprolol Succinate | 572 | $9,557 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 194 | $6,282 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 16 | $6,238 |
| Flecainide Acetate | 49 | $4,316 |
| Amiodarone Hcl | 171 | $3,580 |
| SotalolSotalol Hcl | 130 | $3,575 |
| Mexiletine Hcl | 23 | $3,539 |
| Metoprolol Tartrate | 370 | $2,994 |
| Midodrine Hcl | 37 | $2,771 |
| Enoxaparin Sodium | 83 | $2,720 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $73 | $687,647511 claims |
| NovartisEntresto | $117 | $66,08246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Elyria
- Anish AminColumbus$1.1M
- Walid SalibaCleveland$511K
- Mohamed KanjBeachwood$442K
- John HummelColumbus$275K
- Bruce WilkoffCleveland$213K
- Alexandru CosteaCincinnati$188K
- Auroa BadinColumbus$188K
- Gaurang GandhiCincinnati$179K
- Ralph AugostiniColumbus$174K
- Dina SparanoMayfield Heights$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.